• LinkedIn
  • Twitter
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Advisors
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Medical Affairs
    • Market Access
    • Public Affairs
    • Devices, combination products, IVDs
    • Pharmacovigilance
    • Supply Chain
    • Legal & healthcare compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

Head of SFL Group Shayesteh Fürst-Ladani re-elected as MPP President

On 25 March 2022, during the General Assembly meeting of the Medtech & Pharma Platform Association (MPP), Shayesteh Fürst-Ladani, Head of SFL Group, was unanimously re-elected as President of the MPP.

She stated that “the MPP members’ trust encourages me to continue supporting the MPP activities to achieve our common goals” and recalled that “the MPP plays an important role by bridging the gap between the pharma, medtech and tech sectors to support the development of combined products and ensure patients’ access to innovation”.

The MPP gathers companies from these sectors active in Europe to foster synergies, develop new collaboration models and achieve a balanced regulatory framework for combined products.

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2022 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top